longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

WuXi Biologics

WXXWY

13.6200.29% ( -0.040 )
Delay Closed: Sep 29, 16:00:00 (EDT)
Start trading
OverviewOverviewOptionsOptionsNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 38.81, within the reasonable range, cheaper than 40.37% of the time in the past 5 years, and the industry ranks 11/59, the industry Median -1.75.

38.81xP/E
$13.62Stock price
$0.35Earnings per share
38.81xP/E
Stock price$13.62Earnings per share$0.35

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
34.62x
Typical range
25.94x–49.65x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
010203040

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x40x80x120x160x200x
P/E ratio
Name/Symbol
TMOUSThermo Fisher Scentific
36.07x13.43%$251.28B
DHRUSDanaher
39.70x16.88%$158.95B
AUSAgilent Tech
34.27x12.34%$49.35B
IQVUSIQVIA
32.20x0.96%$44.28B
MTDUSMettler Toledo
34.01x10.40%$30.80B
WXXWYUSWuXi Biologics
38.81x--$27.95B
MEDPUSMedpace
35.33x15.08%$17.36B
QGENUSQiagen NV
22.40x1.15%$9.17B
STVNUSStevanato Group SpA
37.05x8.92%$5.79B
SHCUSSotera Health
32.47x154.32%$5.31B
BLFSUSBioLife Solutions
33.08x1,266.67%$1.92B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.